Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

75%

Ph phase_3

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 3Large-scale testing

1(25.0%)

N/ANon-phased studies

3(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 31 (25.0%)

N/A3 (75.0%)

Trials by Status

completed4100%

Recent Activity

0 active trials

Showing 4 of 4

completednot_applicable

Dietary Supplementation to Increase Serum Choline Levels

NCT02403804

completedphase_3

Essentiale® Paste in Patients With Gastrointestinal Symptoms in Acute or Chronic Liver Diseases

NCT02517385

completednot_applicable

Supplemental Choline and Brain Development in Humans

NCT00678925

completednot_applicable

Study of Phosphatidylcholine in a Patient With Methionine Adenosyltransferase Deficiency

NCT00006061

Clinical Trials (4)

Showing 4 of 4 trials

NCT02403804Not Applicable

Dietary Supplementation to Increase Serum Choline Levels

Completed

NCT02517385Phase 3

Essentiale® Paste in Patients With Gastrointestinal Symptoms in Acute or Chronic Liver Diseases

Completed

NCT00678925Not Applicable

Supplemental Choline and Brain Development in Humans

Completed

NCT00006061Not Applicable

Study of Phosphatidylcholine in a Patient With Methionine Adenosyltransferase Deficiency

Completed

All 4 trials loaded

Drug Details

Intervention Type: DIETARY SUPPLEMENT
Total Trials: 4